Portal de investigación
A Phase 3 Study of the Efficacy, Safety, and Pharmacokinetics of Guselkumab as Openlabel Induction Treatment followed by Randomized Double-blind Subcutaneous Guselkumab Maintenance in Pediatric Participants with Moderately to Severely Active Ulcerative Colitis.
Datos básicos
- Protocolo:
- CNTO1959PUC3001
- EUDRACT:
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Año de incio:
- 2024
- Año de finalización:
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
Resultados del Ensayo Clínico
[Translated article] Knowledge of biological therapy in patients with immune-mediated diseases. BIOINFO study.
Segui-Solanes, Carlos; (...); Borras-Blasco, Joaquin
Article. 10.1016/j.farma.2024.08.002. 2024
[Translated article] New challenges in advanced therapies.
Megías-Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.farma.2024.05.001. 2024
[Translated article] Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice.
Chovi-Trull, Maria; (...); Andres, Jose Luis Poveda
Article. 10.1016/j.farma.2024.12.007. 2025
Benefits of physical activity self-monitoring in patients with haemophilia: a prospective study with one-year follow-up.
Pérez-Alenda S; (...); Núñez-Cortés R
Article. 10.1111/hae.14988. 2024
Cost-effectiveness and cost-utility analysis of haemate-P versus other von willebrand disease treatments in Spain.
Megias-Vericat, Juan E; (...); Yan, Songkai
Article. 10.1080/13696998.2025.2474886. 2025
Datopotamab Deruxtecan Vs Docetaxel in Patients with Non-Small Cell Lung Cancer: Final Overall Survival from TROPION-Lung01
Sands, J.; (...); Ahn, M-J
Meeting Abstract. 2024
Development and testing of a mobile app for systematic collection of patient-reported outcomes (PROs) in patients with hemophilia.
Megias-Vericat, J E; (...); Poveda Andres, J L
Letter. 10.1016/j.thromres.2024.109122. 2024
Effect of beta-glucan supplementation on cystic fibrosis colonic microbiota: an in vitro study.
Asensio-Grau, Andrea; (...); Calvo-Lerma, Joaquim
Article. 10.1038/s41390-023-02944-0. 2023
Exploring histological remission in pediatric patients with celiac disease.
Marset, Gema; (...); Donat, Ester
Article. 10.17235/reed.2024.10697/2024. 2024
Faecal lipid profile as a new marker of fat maldigestion, malabsorption and microbiota.
Asensio-Grau, Andrea; (...); Calvo-Lerma, Joaquim
Article. 10.1038/s41390-024-03209-0. 2024
IMPACT-III and IMPACT-III-P questionnaires: the transcultural adaptation and validation in Spanish families. A SEGHNP (Spanish Society of Pediatric Gastroenterology, Hepatology and Nutrition) multicenter study
Rodriguez-Belvis, M. Velasco; (...); Martin de Carpi, J.
Meeting Abstract. 2024
Long-term evaluation of faecal calprotectin levels in a European cohort of children with cystic fibrosis.
Roca M; (...); Calvo-Lerma J
Article. 10.1136/archdischild-2023-326221. 2023
Mental, emotional and social dimensions of quality of life and their relationship with physical and functional status in adults with haemophilia.
Rodríguez MA; (...); Chimeno-Hernández A
Article. 10.1016/j.thromres.2024.109181. 2024
New challenges of advanced therapies.
Megías-Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.farma.2023.11.008. 2024
Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.
Ballesta-Lopez, Octavio; (...); Poveda-Andres, Jose Luis
Article. 10.3390/ijms26041760. 2025
Rational application of the ESPGHAN 2022 recommendations for the follow up of the paediatric coeliac patient: consensus document of scientific societies (SEGHNP, AEPap, SEPEAP, SEEC, AEG, SEPD, SEMFYC, SEMG and SEMERGEN)
Roman, Enriqueta; (...); Soci Atencion Primaria Adultos SEMFYC SEMG SEMERGEN
Article. 10.1016/j.anpedi.2024.09.001. 2024
Rational application of the ESPGHAN 2022 recommendations for the follow-up of the paediatric coeliac patient: consensus document of scientific societies (SEGHNP, AEPAP, SEPEAP, SEEC, AEG, SEPD, SEMFYC, SEMG and SEMERGEN).
Roman E; (...); Donat YE
Article. 10.1016/j.anpede.2024.09.008. 2024
Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.
Chovi-Trull, Maria; (...); Poveda-Andres, Jose Luis
Article. 10.1136/ejhpharm-2024-004184. 2024
Transcultural adaptation and validation of IMPACT-III and IMPACT-III-P in Spanish families: a multicenter study from SEGHNP.
Velasco Rodriguez-Belvis, Marta; (...); Andres Esteban, Eva Maria
Article. 10.1007/s00431-024-05575-7. 2024